Chronic HCV Infection: Clinical Advances and Eradication Perspectives

 0 Người đánh giá. Xếp hạng trung bình 0

Tác giả: Maria Carla Liberto, Nadia Marascio

Ngôn ngữ: eng

ISBN-13: 978-3036533612

Ký hiệu phân loại:

Thông tin xuất bản: Basel : MDPI - Multidisciplinary Digital Publishing Institute, 2022

Mô tả vật lý: 1 electronic resource (104 p.)

Bộ sưu tập: Tài liệu truy cập mở

ID: 232962

Hepatitis C virus (HCV) chronic infection can determine liver fibrosis, cirrhosis and hepatocellular carcinoma, as well as several extra-hepatic manifestations (i.e., mixed cryoglobulinemia, metabolic syndrome, kidney disease, etc.). HCV infection is asymptomatic until severe stages of disease, thus screening policy in the general population and in specific risk categories is necessary to allow for timely intervention. Despite a high sustained virological response by direct-acting antiviral drugs, a limited percentage of treated subject failed therapy according to resistance associated substitution carried on viral isolates and comorbidities in infected patients. Therefore, tailored therapy is required to cure HCV infection. Failure to comply with these conditions may impair success of HCV eradication expected by 2030. This Special Issue aims to discuss eradication perspectives related to therapy efficacy in patients with chronic diseases, developments in diagnostic procedures and improvements in screening policy.
Tạo bộ sưu tập với mã QR

THƯ VIỆN - TRƯỜNG ĐẠI HỌC CÔNG NGHỆ TP.HCM

ĐT: (028) 71010608 | Email: tt.thuvien@hutech.edu.vn

Copyright @2024 THƯ VIỆN HUTECH